| UniProt ID | 5HT6R_HUMAN | |
|---|---|---|
| UniProt AC | P50406 | |
| Protein Name | 5-hydroxytryptamine receptor 6 | |
| Gene Name | HTR6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 440 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein. |
|
| Protein Description | This is one of the several different receptors for 5-hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that stimulate adenylate cyclase. It has a high affinity for tricyclic psychotropic drugs (By similarity). Controls pyramidal neurons migration during corticogenesis, through the regulation of CDK5 activity (By similarity). Is an activator of TOR signaling. [PubMed: 23027611] | |
| Protein Sequence | MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIALICTQPALRNTSNFFLVSLFTSDLMVGLVVMPPAMLNALYGRWVLARGLCLLWTAFDVMCCSASILNLCLISLDRYLLILSPLRYKLRMTPLRALALVLGAWSLAALASFLPLLLGWHELGHARPPVPGQCRLLASLPFVLVASGLTFFLPSGAICFTYCRILLAARKQAVQVASLTTGMASQASETLQVPRTPRPGVESADSRRLATKHSRKALKASLTLGILLGMFFVTWLPFFVANIVQAVCDCISPGLFDVLTWLGYCNSTMNPIIYPLFMRDFKRALGRFLPCPRCPRERQASLASPSLRTSHSGPRPGLSLQQVLPLPLPPDSDSDSDAGSGGSSGLRLTAQLLLPGEATQDPPLPTRAAAAVNFFNIDPAEPELRPHPLGIPTN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 103 | Phosphorylation | RGLCLLWTAFDVMCC HHHHHHHHHHHHHHH | 19.88 | 24043423 | |
| 111 | Phosphorylation | AFDVMCCSASILNLC HHHHHHHCHHHHHHH | 21.81 | 24043423 | |
| 113 | Phosphorylation | DVMCCSASILNLCLI HHHHHCHHHHHHHHH | 16.00 | 24043423 | |
| 121 | Phosphorylation | ILNLCLISLDRYLLI HHHHHHHHHHHHHHH | 15.98 | 24043423 | |
| 125 | Phosphorylation | CLISLDRYLLILSPL HHHHHHHHHHHHCHH | 12.91 | 16094384 | |
| 130 | Phosphorylation | DRYLLILSPLRYKLR HHHHHHHCHHHHHHC | 18.20 | 24719451 | |
| 227 | Phosphorylation | VQVASLTTGMASQAS HHHHHHHHCCCCHHH | 30.19 | 30257219 | |
| 234 | Phosphorylation | TGMASQASETLQVPR HCCCCHHHCCCCCCC | 24.39 | 27732954 | |
| 236 | Phosphorylation | MASQASETLQVPRTP CCCHHHCCCCCCCCC | 21.72 | 27732954 | |
| 258 | "N6,N6-dimethyllysine" | DSRRLATKHSRKALK HHHHHCHHHHHHHHH | 33.69 | - | |
| 258 | Methylation | DSRRLATKHSRKALK HHHHHCHHHHHHHHH | 33.69 | - | |
| 262 | "N6,N6-dimethyllysine" | LATKHSRKALKASLT HCHHHHHHHHHHHHH | 62.17 | - | |
| 262 | Methylation | LATKHSRKALKASLT HCHHHHHHHHHHHHH | 62.17 | - | |
| 347 | Phosphorylation | CPRERQASLASPSLR CCHHHHHHHCCCCCC | 19.01 | 108417601 | |
| 350 | Phosphorylation | ERQASLASPSLRTSH HHHHHHCCCCCCCCC | 21.95 | 24043423 | |
| 352 | Phosphorylation | QASLASPSLRTSHSG HHHHCCCCCCCCCCC | 28.17 | 24043423 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 350 | S | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of 5HT6R_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of 5HT6R_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CSN5_HUMAN | COPS5 | physical | 20093369 | |
| ATM_HUMAN | ATM | physical | 23027611 | |
| ATR_HUMAN | ATR | physical | 23027611 | |
| ATX10_HUMAN | ATXN10 | physical | 23027611 | |
| CAND2_HUMAN | CAND2 | physical | 23027611 | |
| CDK5_HUMAN | CDK5 | physical | 23027611 | |
| CLH1_HUMAN | CLTC | physical | 23027611 | |
| CND3_HUMAN | NCAPG | physical | 23027611 | |
| COG3_HUMAN | COG3 | physical | 23027611 | |
| COPG2_HUMAN | COPG2 | physical | 23027611 | |
| DYN2_HUMAN | DNM2 | physical | 23027611 | |
| EXOC2_HUMAN | EXOC2 | physical | 23027611 | |
| IPO8_HUMAN | IPO8 | physical | 23027611 | |
| TTI1_HUMAN | TTI1 | physical | 23027611 | |
| MTOR_HUMAN | MTOR | physical | 23027611 | |
| NCDN_HUMAN | NCDN | physical | 23027611 | |
| NF1_HUMAN | NF1 | physical | 23027611 | |
| NSF_HUMAN | NSF | physical | 23027611 | |
| RNBP6_HUMAN | RANBP6 | physical | 23027611 | |
| RPTOR_HUMAN | RPTOR | physical | 23027611 | |
| SMG1_HUMAN | SMG1 | physical | 23027611 | |
| TBCD_HUMAN | TBCD | physical | 23027611 | |
| TELO2_HUMAN | TELO2 | physical | 23027611 | |
| TNPO1_HUMAN | TNPO1 | physical | 23027611 | |
| XPO4_HUMAN | XPO4 | physical | 23027611 | |
| XPOT_HUMAN | XPOT | physical | 23027611 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| D00458 | Quetiapine fumarate (JP16/USAN); Seroquel (TN) | |||||
| D07218 | Metergoline (INN) | |||||
| D08456 | Quetiapine (INN); Norsic (TN) | |||||
| D09918 | Latrepirdine dihydrochloride (USAN); Dimebolin; Dimebon | |||||
| D10099 | Cerlapirdine (USAN) | |||||
| D10100 | Cerlapirdine hydrochloride (USAN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-125, AND MASSSPECTROMETRY. | |